PathAI

PathAI, Inc. develops artificial intelligence-based technology solutions tailored for pathology laboratories, focusing on improving the accuracy and efficiency of cancer diagnosis and treatment. Founded in 2016 and headquartered in Boston, Massachusetts, with an additional office in Austin, Texas, the company aims to assist pathologists in making rapid and precise diagnoses. The PathAI platform employs machine and deep learning techniques on extensive data sets to identify cancerous cells effectively. Moreover, it provides services that address significant challenges faced by the research and pharmaceutical industries, offering end-to-end automation for reliable and scalable solutions. Through its innovative technology, PathAI seeks to advance personalized medicine by identifying patients who may benefit from novel therapies.